Citiford 500mg Injection 2ml

Citiford 500mg Injection 2ml contains Citicoline Sodium, a neuroprotective and nootropic agent that supports brain cell repair and enhances cognitive function in various neurological conditions.

Benefits

Citicoline Sodium helps to protect nerve cells from damage and promotes their survival, contributing to faster neurological recovery. It enhances neuronal membrane repair, boosts neurotransmitter synthesis, and improves overall brain health. The injection aids in reducing cerebral edema and limiting neuronal damage, particularly after neurological events.

Uses and Indications

• Recovery from stroke, including acute ischemic stroke and its neurological sequelae.
• Management of traumatic brain injury and its neurological consequences.
• Treatment of cognitive disorders such as vascular dementia, age-related memory loss, and dementia associated with Parkinson's disease.
• Support for disturbance of consciousness resulting from head injury or brain operation.
• Adjunctive therapy for glaucoma.

The Citiford 500mg Injection 2ml contains:

• Citicoline Sodium equivalent to Citicoline 500mg (active ingredient).
• Water for Injection USP q.s. (excipient).

Dosage and Administration

The dosage and method of administration for Citiford 500mg Injection 2ml must be determined by a qualified doctor based on the patient's condition and age. It is typically administered once or twice daily via intramuscular (IM) or intravenous (IV) injection. Intravenous administration should be performed slowly, over 3 to 5 minutes, or as an intravenous drip infusion at a rate of 40-60 drops per minute.

Storage and Disposal

• Store protected from light at a temperature not exceeding 25°C.
• Keep the ampoule tightly sealed in a cool, dry, and well-ventilated place.
• Keep out of reach of children.

Precautions and Safety

• Citiford 500mg Injection 2ml is not recommended for use in children under 18 years due to limited clinical data.
• Use with caution during pregnancy and lactation; administer only if the potential benefit outweighs the possible risk to the fetus or infant.
• Contraindicated in patients with expressed vagotonia or known hypersensitivity to Citicoline or any of its components.
• Avoid consuming alcohol during treatment, as it may worsen cognitive impairment.
• Inform your doctor about all current medications, allergies, and pre-existing health conditions, especially kidney problems, before starting treatment.
• Citicoline may enhance the effects of levodopa; dosage adjustments for Parkinson's medication may be necessary.
• Do not administer concurrently with medicaments containing meclofenoxate.
• In cases of persistent intracranial haemorrhage, the daily dose should not exceed 1000mg via very slow intravenous administration.

Side Effects and Risks

• Common side effects may include headache, dizziness, insomnia (difficulty in sleeping), anxiety, and gastrointestinal disturbances such as nausea, diarrhea, or stomach pain.
• Other possible side effects include hypotension (low blood pressure), weakness, rash, allergic reactions, injection site pain, blurred vision, transient blood pressure changes, flushing, or changes in heart rate.
• Most side effects are mild and temporary; however, if they persist or worsen, consult your doctor immediately.

Disclaimer

Use this medicine only under the prescription and guidance of a qualified doctor or pharmacist.